AllianceBernstein’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205M Buy
2,380,344
+629,512
+36% +$53.5M 0.07% 201
2026
Q1
$153M Sell
1,750,832
-94,126
-5% -$8.45M 0.05% 260
2025
Q4
$161M Sell
1,844,958
-210,225
-10% -$16M 0.05% 265
2025
Q3
$118M Buy
2,055,183
+1,908,795
+1,304% +$110M 0.04% 347
2025
Q2
$8.64M Sell
146,388
-29,019
-17% -$1.87M ﹤0.01% 1236
2025
Q1
$12.8M Buy
175,407
+1,906
+1% +$157K ﹤0.01% 1042
2024
Q4
$14.4M Buy
173,501
+21,516
+14% +$1.7M ﹤0.01% 1020
2024
Q3
$10.9M Sell
151,985
-3,914
-3% -$276K ﹤0.01% 1141
2024
Q2
$10.7M Sell
155,899
-7,410
-5% -$443K ﹤0.01% 1133
2024
Q1
$8.76M Buy
163,309
+231
+0.1% +$12.4K ﹤0.01% 1223
2023
Q4
$8.69M Sell
163,078
-433
-0.3% -$21.1K ﹤0.01% 1231
2023
Q3
$8.12M Buy
163,511
+44,367
+37% +$2.48M ﹤0.01% 1195
2023
Q2
$7.09M Buy
119,144
+4,370
+4% +$249K ﹤0.01% 1289
2023
Q1
$6.5M Sell
114,774
-1,774
-2% -$114K ﹤0.01% 1294
2022
Q4
$8.66M Sell
116,548
-1,847
-2% -$126K ﹤0.01% 1171
2022
Q3
$7.05M Sell
118,395
-4,887
-4% -$294K ﹤0.01% 1246
2022
Q2
$6.92M Sell
123,282
-33,754
-21% -$2.22M ﹤0.01% 1305
2022
Q1
$11.6M Sell
157,036
-1,139
-0.7% -$79.2K ﹤0.01% 1144
2021
Q4
$11.4M Buy
158,175
+983
+0.6% +$71.4K ﹤0.01% 1179
2021
Q3
$12M Sell
157,192
-797
-0.5% -$64K ﹤0.01% 1145
2021
Q2
$12.2M Buy
157,989
+1,150
+0.7% +$81.8K ﹤0.01% 1133
2021
Q1
$9.67M Buy
156,839
+2,802
+2% +$177K ﹤0.01% 1223
2020
Q4
$10M Sell
154,037
-1,460
-0.9% -$83.9K ﹤0.01% 1131
2020
Q3
$7.7M Sell
155,497
-23,934
-13% -$1.23M ﹤0.01% 1133
2020
Q2
$8.56M Sell
179,431
-80,790
-31% -$3.9M 0.01% 1067
2020
Q1
$11.1M Sell
260,221
-4,990
-2% -$247K 0.01% 874
2019
Q4
$15.6M Buy
265,211
+620
+0.2% +$33.7K 0.01% 899
2019
Q3
$13.5M Sell
264,591
-835
-0.3% -$39.8K 0.01% 921
2019
Q2
$11.2M Buy
265,426
+14,510
+6% +$630K 0.01% 1003
2019
Q1
$12.4M Sell
250,916
-31,220
-11% -$1.41M 0.01% 961
2018
Q4
$12.2M Buy
282,136
+81,975
+41% +$4.09M 0.01% 909
2018
Q3
$11.4M Sell
200,161
-40
-0% -$2.1K 0.01% 937
2018
Q2
$10.1M Buy
200,201
+43,070
+27% +$2.25M 0.01% 962
2018
Q1
$7.83M Sell
157,131
-13,494
-8% -$634K 0.01% 1015
2017
Q4
$7.01M Sell
170,625
-3,486
-2% -$122K 0.01% 1062
2017
Q3
$5.17M Sell
174,111
-5,190
-3% -$158K ﹤0.01% 1191
2017
Q2
$5.94M Buy
179,301
+69,160
+63% +$2.17M ﹤0.01% 1123
2017
Q1
$3.26M Sell
110,141
-8,700
-7% -$237K ﹤0.01% 1459
2016
Q4
$2.95M Buy
118,841
+3,011
+3% +$68.4K ﹤0.01% 1558
2016
Q3
$2.61M Hold
115,830
﹤0.01% 1575
2016
Q2
$2.76M Buy
115,830
+6,400
+6% +$153K ﹤0.01% 1445
2016
Q1
$2.6M Hold
109,430
﹤0.01% 1408
2015
Q4
$3.04M Sell
109,430
-6,000
-5% -$151K ﹤0.01% 1319
2015
Q3
$2.38M Sell
115,430
-2,770
-2% -$70.2K ﹤0.01% 1516
2015
Q2
$3.03M Hold
118,200
﹤0.01% 1450
2015
Q1
$2.98M Hold
118,200
﹤0.01% 1443
2014
Q4
$2.81M Hold
118,200
﹤0.01% 1479
2014
Q3
$2.33M Hold
118,200
﹤0.01% 1605
2014
Q2
$2.83M Hold
118,200
﹤0.01% 1513
2014
Q1
$3.14M Buy
118,200
+6,100
+5% +$145K ﹤0.01% 1396
2013
Q4
$2.26M Sell
112,100
-5,200
-4% -$96.5K ﹤0.01% 1620
2013
Q3
$2.05M Buy
117,300
+5,292
+5% +$91.6K ﹤0.01% 1657
2013
Q2
$1.89M Buy
+112,008
New +$1.73M ﹤0.01% 1643

Other funds holding GMED

AllianceBernstein's GMED Position: Q2 2026 in Review

AllianceBernstein increased its Globus Medical (GMED) stake by 36% in Q2 2026, buying an estimated $53.5M and bringing the position to 2,380,344 shares worth $205M. The position accounts for 0.07% of the portfolio, ranked #201.

AllianceBernstein first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • AllianceBernstein held 2,380,344 shares of Globus Medical worth $205M as of Q2 2026.
  • AllianceBernstein bought 629,512 Globus Medical shares in Q2 2026, an estimated $53.5M.
  • Globus Medical made up 0.07% of AllianceBernstein's portfolio in Q2 2026, its #201 holding.
  • AllianceBernstein first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
  • 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.